95% CI 1.09 to 3.93), in particular cancers of the oral cavity, pharynx and larynx (SMR 2.13, 95% CI 1.06 to 3.81). There were more deaths from multiple myeloma and Hodgkin disease than expected, but ...

Outcomes of interest in this study were time from diagnosis to initial prescription fill for an oral multiple myeloma (MM) medication and time from initial diagnosis to receipt of any treatment ...

Outcomes of interest in this study were time from diagnosis to initial prescription fill for an oral multiple myeloma (MM) medication and time from initial diagnosis to receipt of any treatment ...

Non-secretory myeloma is a rare form of myeloma. In people with this form, myeloma cells do not release an abnormal protein called paraprotein, making it harder to diagnose than other types of ...

Revlimid (lenalidomide) is a brand-name oral capsule prescribed to treat multiple myeloma and certain other blood cell cancers in adults. This article covers topics such as side effects ...

Multiple myeloma is a type of cancer where plasma cells in bone marrow replicate out of control. Doctors use the acronym CRAB to diagnose myeloma by identifying four symptoms. The National Cancer ...

This medication is an anti-cancer drug, prescribed for certain types of cancers like multiple myeloma, brain tumor, Hodgkin’s and non – Hodgkin’s lymphoma. The medication restricts the ...

Myeloma, or multiple myeloma, is a cancer affecting a particular type of blood cells, called plasma cells. Myeloma is most common in people over 60 and is characterized by the accumulation of ...

This gave rise to the Axion Dark-Matter Birefringent Cavity (ADBC) experiment, which first started collecting data in 2022. "We wanted to demonstrate experimentally how to use these tools to pull ...

About 18,000 Americans are diagnosed with a new case of oropharyngeal cancer each year, with a UK head, neck and thyroid surgeon pointing the finger at oral sex. Oropharyngeal cancer is a type of ...

Credit: Michael Vi/Shutterstock The European label for Johnson and Johnson Innovation Medicine’s (J&J) Darzalex (daratumumab) has been expanded to include patients with newly diagnosed multiple ...